Titlesort descending Credit Type Event date Cost
APPOS Washington DC 2025
    • 9.50 AMA PRA Category 1 Credit™
    • 9.50 ANCC
    • 9.50 ACPE Pharmacy
    • 2.75 Pharmacology
 Live 05/02/2025 - 4:00am PDT $65.00
Best Practices for Opioid Pain Management in Patients with Cancer
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Bispecific Therapy in Cancer Treatment
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Cardiotoxicity in Oncology Patients: Risks, Diagnostics, and Interventions
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Current Treatment Paradigms for Head and Neck Cancers
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Examining and Addressing Disparities in Multiple Myeloma Treatment & Outcomes (On-Demand)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Expanding the Role of Immunotherapy: New Regimens for Use in the Adjuvant and Neoadjuvant Settings
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Genomic Profiling for Clinical Decision Making in Hematologic Malignancies
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 0.50 Pharmacology
 Live 02/06/2025 - 8:55pm PST $0.00
Hitting the Target: Updates and Review in Genotype Directed Therapy for Non-Small Cell Lung Cancer
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Improving Outcomes in Advanced Prostate Cancer (On-Demand)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 0.50 Pharmacology
 Enduring $0.00
Integrative Oncology: Supporting Healing Before, During, and After
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Management of Hypersensitivity Reactions in Oncology Patients
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 0.75 Pharmacology
 Live 03/25/2025 - 3:55pm PDT $0.00
Melanoma Management in 2024
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Navigating the Terrain: Insights into the Current Landscape, Treatment Strategies, and a Clinical Trial of Triple Negative Breast Cancer
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ANCC
 Enduring $0.00
Neuroendocrine Neoplasms: Not All Hoofbeats Are Horses
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ANCC
 Enduring $0.00

Pages